Releases Geral
ApplyBoard Launches Abbie, the World’s First AI Advisor for Studying Abroad
AGÊNCIA DE COMUNICAÇÃO Conteúdo de responsabilidade da empresa 18 de junho de 2024
ApplyBoard
Kitchener, Ontario, Canada, June 18, 2024 (GLOBE NEWSWIRE) — ApplyBoard, the leading international student mobility platform, today announced the launch of Abbie, an industry-first AI advisor designed to revolutionize the study abroad experience. Leveraging Microsoft Azure’s OpenAI platform, the patent-pending product is powered by the latest GPT models to provide personalized, high-quality support to students, recruitment agents, and other stakeholders at every stage of the international education journey.
As an all-in-one advisor, Abbie offers a wealth of knowledge and resources, including comprehensive information on global institutions, programs, and application processes. With its advanced natural language processing capabilities, Abbie can provide customized guidance based on each student’s unique profile, ensuring they receive the most relevant and accurate advice for their specific educational needs and aspirations. Abbie can answer a student’s question in seconds, a process that previously took hours or days, making the program matching and application process faster and easier than ever.
“This launch represents a major milestone in ApplyBoard’s mission to make education accessible to students worldwide,” said Meti Basiri, Co-Founder & CEO, ApplyBoard. “By harnessing the power of AI, we are revolutionizing the way students navigate the complex and cumbersome study abroad landscape. Abbie is more than just a tool; it’s a manifestation of our commitment to student success and our vision for the future of international education.”
Abbie draws upon ApplyBoard’s extensive knowledge base, including institution and program information, anonymized student search and application data, and insights from ApplyBoard’s knowledge base Assist, ApplyInsights, and other proprietary resources. This comprehensive dataset also enables Abbie to provide unparalleled support and strategic guidance to recruitment agents, helping them better serve their students.
“The development of Abbie is a testament to the incredible role AI will have in transforming the education sector,” said Dr. Haitham Amar, Head of AI Strategy, ApplyBoard. “By combining cutting-edge technology with ApplyBoard’s deep expertise in international student mobility, we have created a tool that not only simplifies the international education process but also empowers students and recruitment agents with the insights they need to succeed, in a fraction of the time it used to take.”
Key features include:
- Personalized expertise: Tailored guidance based on each student’s unique profile and needs
- All-in-one advisor: Comprehensive support across the entire study abroad journey, from program discovery to application assistance and beyond
- Instant support: 24/7 availability directly within the ApplyBoard platform
- Multilingual capabilities: Support for multiple languages to serve a global audience
About ApplyBoard
ApplyBoard empowers students around the world to access the best education by simplifying the study abroad search, application, and acceptance process to more than 1,500 institutions across Canada, the United States, the United Kingdom, Australia, and Ireland. Headquartered in Kitchener, Ontario, Canada, ApplyBoard has helped over 1 million students from more than 150 countries along their educational journeys since 2015. To learn more, visit www.applyboard.com.
Attachment
Brooke Kelly ApplyBoard brooke.kelly@applyboard.com
A OESP nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP e sao de inteira responsabilidade da GlobeNewswire
Leia também
-
Releases Geral Global Liver Institute Welcomes Larry R. Holden as CEO
3 de setembro de 2024Washington, DC, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed
Saiba Mais -
Releases Geral Confraternizações seguem tendências em 2024
22 de agosto de 2024Atibaia, São Paulo--(DINO - 08 ago, 2024) - As confraternizações são momentos importantes para fortalecer laços, seja no ambiente corporativo, entre am
Saiba Mais -
Releases Geral Zenas BioPharma Publica Fase 2 do Estudo Clínico do Obexelimabe, um Tratamento Investigativo da Doença Relacionada à IgG4 (IgG4-RD), no The Lancet Rheumatology
2 de agosto de 2023DINO DIVULGADOR DE NOTÍCIAS Waltham/MA–(DINO – 02 ago, 2023) – Estudo revelou que o obexelimabe produziu melhora clínica rápida, forte e sustentada, incluindo remissão clínica
Saiba Mais